Improving tumour heterogeneity MRI assessment with histograms.
about
Radiation treatment monitoring using multimodal functional imaging: PET/CT ((18)F-Fluoromisonidazole & (18)F-Fluorocholine) and DCE-US.Diffusion MRI in early cancer therapeutic response assessment.Non-invasive quantification of tumour heterogeneity in water diffusivity to differentiate malignant from benign tissues of urinary bladder: a phase I study.Histogram Analysis of Diffusion Weighted Imaging at 3T is Useful for Prediction of Lymphatic Metastatic Spread, Proliferative Activity, and Cellularity in Thyroid Cancer.Dynamic Contrast-Enhanced MRI Perfusion Parameters as Imaging Biomarkers of Angiogenesis.Radiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer.Non-small cell lung cancer: Whole-lesion histogram analysis of the apparent diffusion coefficient for assessment of tumor grade, lymphovascular invasion and pleural invasionSemiautomated Workflow for Clinically Streamlined Glioma Parametric Response MappingLack of robustness of textural measures obtained from 3D brain tumor MRIs impose a need for standardization.Texture analysis on parametric maps derived from dynamic contrast-enhanced magnetic resonance imaging in head and neck cancerDEMARCATE: Density-based magnetic resonance image clustering for assessing tumor heterogeneity in cancer.Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.Imaging intratumor heterogeneity: role in therapy response, resistance, and clinical outcome.Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.Relationship between Glioblastoma Heterogeneity and Survival Time: An MR Imaging Texture Analysis.Quantification of hepatocellular carcinoma heterogeneity with multiparametric magnetic resonance imagingFunctional MRI for quantitative treatment response prediction in locally advanced rectal cancer.Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas.MRI Evaluation of Non-Necrotic T2-Hyperintense Foci in Pediatric Diffuse Intrinsic Pontine Glioma.Apparent Diffusion Coefficient Histograms of Human Papillomavirus-Positive and Human Papillomavirus-Negative Head and Neck Squamous Cell Carcinoma: Assessment of Tumor Heterogeneity and Comparison with Histopathology.Tumour heterogeneity in glioblastoma assessed by MRI texture analysis: a potential marker of survival.MRI Texture Analysis Reflects Histopathology Parameters in Thyroid Cancer - A First Preliminary Study.Clinical Applications of Contrast-Enhanced Perfusion MRI Techniques in Gliomas: Recent Advances and Current Challenges.Quantitative Assessment of Heterogeneity in Bladder Tumor MRI Diffusivity: Can Response be Predicted Prior to Neoadjuvant Chemotherapy?From the Cover: MagneticResonance Imaging Reveals Progressive Brain Injury in Rats Acutely Intoxicated With Diisopropylfluorophosphate.Whole-lesion apparent diffusion coefficient (ADC) metrics as a marker of breast tumour characterization-comparison between ADC value and ADC entropy.Cancer Metabolism and Tumor Heterogeneity: Imaging Perspectives Using MR Imaging and Spectroscopy.Diffusion-weighted MRI and intravoxel incoherent motion model for diagnosis of pediatric solid abdominal tumors.ADC-derived spatial features can accurately classify adnexal lesions.ADC Histogram Analysis of Cervical Cancer Aids Detecting Lymphatic Metastases-a Preliminary Study.Monitoring In-Vivo the Mammary Gland Microstructure during Morphogenesis from Lactation to Post-Weaning Using Diffusion Tensor MRI.Histogram analysis of diffusion kurtosis imaging derived maps may distinguish between low and high grade gliomas before surgery.Diagnostic value of MRI-based 3D texture analysis for tissue characterisation and discrimination of low-grade chondrosarcoma from enchondroma: a pilot study.Histogram analysis of apparent diffusion coefficient maps for the differentiation between lymphoma and metastatic lymph nodes of squamous cell carcinoma in head and neck region.Diffusion-weighted imaging: Apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer.Characterization of breast masses as benign or malignant at 3.0T MRI with whole-lesion histogram analysis of the apparent diffusion coefficient.Hybrid RGSA and Support Vector Machine Framework for Three-Dimensional Magnetic Resonance Brain Tumor Classification.Voxel-based evidence of perfusion normalization in glioblastoma patients included in a phase I-II trial of radiotherapy/tipifarnib combination.Histogram analysis of apparent diffusion coefficient maps for assessing thymic epithelial tumours: correlation with world health organization classification and clinical staging.Histogram analysis of apparent diffusion coefficients after neoadjuvant chemotherapy in breast cancer.
P2860
Q30395717-BCFB9EA1-C4F1-4B38-81BE-313778D455E9Q31037179-50C5953E-1ADE-4B7B-A955-5848F588F45AQ31123235-5E6B106F-5898-4D09-BEDA-28F51691B60BQ33624735-2CCEB3E7-EDE3-476B-86D3-C286B464C0CFQ36236333-CEC22E7B-3DEB-46AE-B4E0-9A4CEB56A568Q36271681-0ED7DB0F-5DED-433C-933A-0F4264A0A116Q36282874-AAF69C2F-C0FF-41CA-958F-2C733303D57CQ36305786-EF05575D-4126-4699-AD98-938981ACBE90Q36393965-BDBF5E01-5F5F-4C11-8642-EB45491AB220Q36515722-DF06223D-D583-49E3-9D13-D0683DE3BB5FQ37064197-F040F19E-3A8E-40DC-9A0D-3BF1735EF1F0Q37496863-C1C94ABB-C954-4268-88F4-D4CD90E09919Q38271116-36A2B033-BD9D-4051-BBB0-A7BD5533DF4EQ38606106-6EBD1D0C-3EB2-41B0-89A3-67B6EE3A5D0CQ38701609-1B5C3DF2-E011-4ADB-9E37-F1053B20D878Q38760629-34877BFD-EBE1-459D-A740-AAB092DC5D79Q39068294-387280D6-7E16-43BD-8870-CF72FC1F27AEQ39647863-BB4F549B-7B82-4DCF-9DD4-3A6DD16E22A1Q39752215-A7D2E24C-5533-452E-B04D-1BF09EF45B4DQ40045139-441E059D-C33F-463D-AC2B-7096E5EC9E97Q42019179-4B06A274-FB7D-46AB-A854-8B2AD4065610Q42379602-C7FD663C-2B57-4D46-91B3-034C991F1F24Q43376098-B17BB844-762A-4D56-A6F8-10C3D98E780CQ44138102-3B627665-0863-4ED8-86DB-FB8DE6605A50Q46005401-035B874F-E57C-4F81-AB43-5925F155C894Q47135880-6A4736A0-3F55-45F4-9AED-67FBD756FAB7Q47162047-455E713C-9006-4A8E-B745-483174CF2B24Q47437270-A57B855C-CBDA-4F6C-929E-94E394206A9DQ47681139-351BA81A-80DC-4893-B8A2-7A9A4132B63AQ47823917-33C51C1E-03AF-42C3-B23D-5FC01C41CB87Q47972614-F6529D5F-9C3D-40F4-980F-005CF23D2DB7Q48293022-7EF355EB-D187-41F4-9292-1A2A28E2FFC9Q50201329-E53F3147-33D1-4269-827E-51B4A2B5C3BDQ50224658-760501E0-34A8-4416-8F33-FA9E8450D7F0Q50755839-52A63429-A100-456B-B94C-56738D986F38Q50858628-7EF17676-08FE-4F64-9C62-422549E10DD7Q51669590-2ED4EC8D-30A2-45B4-A17D-011330DF6D3AQ52151865-680AC97A-27EC-4BE9-8FB9-154C8871AE62Q52743015-73B500D6-EF91-4CF2-AC3D-C71A404E0F2AQ53582375-5B790A70-05E2-4FD9-B9D8-E19A84B87C0D
P2860
Improving tumour heterogeneity MRI assessment with histograms.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Improving tumour heterogeneity MRI assessment with histograms.
@ast
Improving tumour heterogeneity MRI assessment with histograms.
@en
Improving tumour heterogeneity MRI assessment with histograms.
@nl
type
label
Improving tumour heterogeneity MRI assessment with histograms.
@ast
Improving tumour heterogeneity MRI assessment with histograms.
@en
Improving tumour heterogeneity MRI assessment with histograms.
@nl
prefLabel
Improving tumour heterogeneity MRI assessment with histograms.
@ast
Improving tumour heterogeneity MRI assessment with histograms.
@en
Improving tumour heterogeneity MRI assessment with histograms.
@nl
P2860
P3181
P356
P1476
Improving tumour heterogeneity MRI assessment with histograms.
@en
P2093
P2860
P2888
P304
P3181
P356
10.1038/BJC.2014.512
P407
P5008
P577
2014-12-09T00:00:00Z
P5875
P6179
1034330279